Health Team

UNC researcher: Too early to approve any coronavirus vaccine, plasma treatment still uncertain

Ralph Baric, a coronavirus researcher at the Gillings School of Global Public Health, discusses vaccines for the virus, using plasma from infected people as a treatment and the case of a Hong Kong man who was infected twice.